E. Wei

发表

End points in dermatologic clinical trials: A review for clinicians.

R. Kirsner, W. Eaglstein, E. Wei, 2016, Journal of the American Academy of Dermatology.

Giant proliferating trichilemmal cyst arising from a nevus sebaceus growing for 30 years

G. Elgart, D. Aickara, J. H. Cho-Vega, 2017, Journal of cutaneous pathology.

Lymphopenia during the COVID-19 infection: What it shows and what can be learned

S. Tavakolpour, M. Rashidian, E. Wei, 2020, Immunology Letters.

Having a first-degree relative with melanoma increases lifetime risk of melanoma, squamous cell carcinoma, and basal cell carcinoma.

H. Nan, E. Wei, Xin Li, 2019, Journal of the American Academy of Dermatology.

Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.

A. Qureshi, Jiali Han, Jennifer Y. Lin, 2016, Journal of the American Academy of Dermatology.

Indoor tanning early in life is associated with increased risk of anxiety and depression later in life.

H. Nan, O. Okereke, E. Wei, 2021, Journal of the American Academy of Dermatology.

Unilateral, localized bullous pemphigoid in a patient with chronic venous stasis

S. Granter, C. Shi, A. Charrow, 2018, JAAD case reports.

Nail Changes of Systemic Amyloidosis After Bone-Marrow Transplantation in a Patient With Multiple Myeloma.

A. Tosti, J. H. Cho-Vega, K. Oberlin, 2016, JAMA dermatology.

Bullous pemphigoid after anti-PD-1 therapy: a retrospective case-control study evaluating impact on tumor response and survival outcomes.

C. Nelson, A. Giobbie-Hurder, C. Lian, 2020, Journal of the American Academy of Dermatology.

Risk Factors for the Development of Bullous Pemphigoid in US Patients Receiving Immune Checkpoint Inhibitors.

C. Nelson, A. Giobbie-Hurder, N. LeBoeuf, 2022, JAMA dermatology.

Reply to: "Comment on Bullous pemphigoid after anti-PD-1 therapy: a retrospective case-control study evaluating impact on tumor response and survival outcomes".

C. Nelson, A. Giobbie-Hurder, C. Lian, 2020, Journal of the American Academy of Dermatology.

Rates of Dermoscopy Use for Melanoma Diagnosis in the Miami VA Medical Center

F. Ma, J. Keri, Lucy L. Chen, 2017, JAMA dermatology.

Extremity nevus count is an independent risk factor for basal cell carcinoma and melanoma, but not squamous cell carcinoma

H. Nan, E. Wei, Xin Li, 2019, Journal of the American Academy of Dermatology.

Advanced care planning, code status and end‐of‐life care in patients with bullous pemphigoid

L. Thompson, A. Charrow, E. Wei, 2021, The British journal of dermatology.

Recent dermatology visit is associated with thinner Breslow depth nodular melanomas

F. Ma, J. Keri, Lucy L. Chen, 2019, Journal of American Academy of Dermatology.

Accuracy of conflict-of-interest disclosures reported by physicians.

Mohit Bhandari, M. Bhandari, M. Kocher, 2009, The New England journal of medicine.

Alopecia in Systemic Amyloidosis: Trichoscopic-Pathologic Correlation

C. Milikowski, A. Tosti, M. Miteva, 2015, International Journal of Trichology.

An integrated pharmacological, structural, and genetic analysis of extracellular versus intracellular ROS production in neutrophils.

M. Yaffe, U. Heinemann, Yu‐ming M. Huang, 2022, Journal of molecular biology.

Impact of Biologic Therapy on Cancer Outcomes in Patients with Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid.

A. Giobbie-Hurder, N. LeBoeuf, A. Mostaghimi, 2022, Journal of the American Academy of Dermatology.

Missed Drug-Induced Bullous Pemphigoid Leads to Longer Immunosuppression Than Recognized Cases: A 9-Year Retrospective Review.

S.T. Chen, E. Wei, G. Molina, 2020, Journal of the American Academy of Dermatology.

Response to: "Missed induced bullous pemphigoid: when the anamnesis is the cure," a Comment on: "Missed Drug-Induced Bullous Pemphigoid Leads to Longer Immunosuppression Than Recognized Cases: A 9-Year Retrospective Review".

S.T. Chen, E. Wei, G. Molina, 2020, Journal of the American Academy of Dermatology.